Compound details
Paucine
| Compound ID | CDAMM02366 |
|---|---|
| Common name | Paucine | IUPAC name | N-(4-aminobutyl)-3-(3,4-dihydroxyphenyl)prop-2-enamide |
| Molecular formula | C13H18N2O3 |
| Retention time | 1.18 |
|---|---|
| Adduct | [M+K]+ |
| Actual mz | 289.095 | Theoretical mz | 289.095 |
| Error | 0.2 |
| Ionizaton mode | Positive |
| Instrument type | LC-MS/MS-QTOF, spectrum predicted by MS-DIAL v4.9 integrated with MS-FINDER 3.60 |
| Score | 6.6844 |
| Inchi key | KTZNZCYTXQYEHT-XQRVVYSFSA-N |
|---|---|
| Smiles | OC(=NCCCCN)C=CC1=CC=C(O)C(O)=C1 |
| Superclass | Benzenoids |
| Class | Phenols |
| Uniprot ID | Gene name | Target name | TTD_ID | Prediction source |
|---|---|---|---|---|
| P02766 | TTR | Transthyretin | T86462 | SEA |
| P05067 | APP | Beta amyloid A4 protein | T87024 | SEA |
| P43166 | CA7 | Carbonic anhydrase VII | T37541 | SEA |
| P23280 | CA6 | Carbonic anhydrase VI | T06569 | SEA |
| Q9ULX7 | CA14 | Carbonic anhydrase XIV | T31992 | SEA |
| P14780 | MMP9 | Matrix metalloproteinase 9 | T54156 | SEA |
| P19838 | NFKB1 | Nuclear factor NF-kappa-B p105 subunit | T83145 | SEA |
| Q09472 | EP300 | Histone acetyltransferase p300 | T25956 | SEA |
| P10636 | MAPT | Microtubule-associated protein tau | T45593 | SEA |
| Q04760 | GLO1 | Glyoxalase I | T88285 | SEA |
| Q16236 | NFE2L2 | Nuclear factor erythroid 2-related factor 2 | T88505 | SEA |
| P10809 | HSPD1 | Mitochondrial matrix protein P1 | T11283 | SEA |
| TTD_ID | Disease_ID | Disease name | ICD_11 | Uniprot ID | Gene names |
|---|---|---|---|---|---|
| T86462 | DI0026 | Amyloidosis | [ICD-11: 5D00] | P02766 | TTR |
| T87024 | DI0025 | Alzheimer disease | [ICD-11: 8A20] | P05067 | APP |
| T87024 | DI0122 | Diagnostic imaging | [ICD-11: N.A.] | P05067 | APP |
| T06569 | DI0046 | Bacterial infection | [ICD-11: 1A00-1C4Z] | P23280 | CA6 |
| T06569 | DI0372 | Seborrhoeic dermatitis | [ICD-11: EA81] | P23280 | CA6 |
| T31992 | DI0046 | Bacterial infection | [ICD-11: 1A00-1C4Z] | Q9ULX7 | CA14 |
| T31992 | DI0204 | Inborn metabolism deficiency | [ICD-11: 5C50-5C59] | Q9ULX7 | CA14 |
| T54156 | DI0219 | Ischaemic/haemorrhagic stroke | [ICD-11: 8B20] | P14780 | MMP9 |
| T54156 | DI0391 | Solid tumour/cancer | [ICD-11: 2A00-2F9Z] | P14780 | MMP9 |
| T54156 | DI0395 | Stomach cancer | [ICD-11: 2B72] | P14780 | MMP9 |
| T54156 | DI0419 | Ulcerative colitis | [ICD-11: DD71] | P14780 | MMP9 |
| T83145 | DI0218 | Irritable bowel syndrome | [ICD-11: DD91] | P19838 | NFKB1 |
| T83145 | DI0366 | Rheumatoid arthritis | [ICD-11: FA20] | P19838 | NFKB1 |
| T25956 | DI0346 | Prostate cancer | [ICD-11: 2C82] | Q09472 | EP300 |
| T25956 | DI0391 | Solid tumour/cancer | [ICD-11: 2A00-2F9Z] | Q09472 | EP300 |
| T45593 | DI0012 | Acute myeloid leukaemia | [ICD-11: 2A60] | P10636 | MAPT |
| T45593 | DI0025 | Alzheimer disease | [ICD-11: 8A20] | P10636 | MAPT |
| T45593 | DI0265 | Mild neurocognitive disorder | [ICD-11: 6D71] | P10636 | MAPT |
| T88285 | DI0210 | Influenza | [ICD-11: 1E30-1E32] | Q04760 | GLO1 |
| T88505 | DI0038 | Ataxic disorder | [ICD-11: 8A03] | Q16236 | NFE2L2 |
| T11283 | DI0120 | Diabetes mellitus | [ICD-11: 5A10] | P10809 | HSPD1 |